A controlled feeding trial with 43 overweight adults found that consuming 209 grams of avocado daily for four weeks increased beneficial short-chain fatty acids by 28% and reduced gut inflammation marker calprotectin by 30% compared to a typical American diet. The avocado intervention also decreased secondary bile acids by 34% and boosted specific beneficial bacteria including Alistipes communis and Bacteroides uniformis, while reducing secretory IgA levels by 34%. Notably, whole avocados produced distinct microbiome changes compared to supplements providing equivalent amounts of monounsaturated fats and fiber, demonstrating that food matrix matters beyond isolated nutrients. This crossover design strengthens causality by having participants serve as their own controls across three different dietary interventions. The findings suggest avocados' unique combination of healthy fats, fiber, and bioactive compounds synergistically supports gut barrier function and reduces intestinal inflammation. However, this is a preprint awaiting peer review, so results may change. The relatively small sample size and focus on overweight individuals limits generalizability. While confirmatory of avocados' health benefits, the study provides valuable mechanistic insights into how whole foods outperform their constituent parts for gastrointestinal wellness.